Active Colitis Attenuates Ventricular Excitation–Contraction Coupling by T-Tubular Remodeling

Read full text Summarise with VIRAT
Authors: Edward J. Ouille, Carlos H. Pereira, Ygor Marinho, Giedrius Kanaporis, Kathrin Banach
Cited by: 0
References: 55

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In patients, extraintestinal manifestations of inflammatory bowel disease (IBD) are attenuated ventricular contractile function and arrhythmia. To determine the mechanism of IBD-induced changes in ventricular function, we used a mouse model of dextran sodium sulfate (3.5% weight/volume; 7 days)-induced colitis. Changes in cardiac function were quantified in isolated ventricular myocytes (VM) by cell shortening, imaging of [Ca2+]i, reactive oxygen species (ROS), and t-tubular density. During colitis, VMs exhibited attenuated cell-shortening and altered Ca2+-handling properties. A prolonged Ca2+ transient (CaT) rise time correlated with an increased coefficient of variation in the subcellular Ca2+ release and an attenuated t-tubular density. T-tubular loss was accompanied by increased ROS production, calpain-2 (CAPN2) expression, junctophilin-2 (JPH-2) cleavage, and autophagy. Inhibition of Angiotensin-converting enzyme during colitis (Perindopril: 3 mg/kg/day) prevented the increase in CAPN2, ROS production, autophagy, and t-tubular remodeling. It failed, however, to restore full length JPH-2. We conclude that, during IBD, the angiotensin II (AngII)-induced loss of t-tubular integrity and altered cellular Ca2+ handling can be prevented by suppression of the AngII-dependent increase in CAPN2 and autophagy and thus suppression of AngII signaling might benefit IBD patients with cardiac manifestations of the disease.

Fields of Study & Subjects

Cardiac electrophysiology and arrhythmias Cardiac Fibrosis and Remodeling Inflammatory Bowel Disease

Publication details

Journal / source
Biomolecules
Volume
16
Issue
4
Pages
503–503
Publication date
27 March 2026
Language
EN